Lumipulse® G FT3-III (Free Triiodothyronine)
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free triiodothyronine (FT3) in serum or plasma. This assay uses a mouse monoclonal antibody.
The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
Product number 297582
Product number 233825
-
Details
Assay technology
CLEIA - ChemiLuminescent Enzyme Immunoassay
Test principle: One-step competitive assay
Clinical background
FT3 (Free triiodothyronine)
Free triiodothyronine is maintained at a constant level in the blood by the hypothalamus-pituitary-thyroid system.
Therefore this assay can be a sensitive indicator to help in measuring thyroid function and peripheral T4 metabolism.
While the blood T3 concentration changes with quantitative and qualitative variations in TBP (thyroxine-binding protein), the blood FT3 is not influenced therefore more closely mirrors the in vivo metabolic status.
The FT3 assay is useful in diagnosis and monitoring therapeutic effect of various thyroid diseases.
See the LUMIPULSE G1200 working in this video:
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all regulatory documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Regulatory product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
FAQ
How does the coronavirus disease Covid-19 impact Fujirebio's operations?
Please see the following statement on the impact of coronavirus disease Covid-19 on the operations of Fujirebio Europe (updated January 19, 2021).
-
Related products
-
Product inquiry
